Cambridge Investment Research Advisors
DPLO

Cambridge Investment Research Advisors’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Cambridge Investment Research Advisors’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-466,082
Closed -$1.86M – 2546
2019
Q4 		$1.86M Sell
466,082
-340,737
-42% -$1.6M 0.01% 825
2019
Q3 		$3.95M Sell
806,819
-200
-0% -$1.12K 0.03% 512
2019
Q2 		$4.92M Sell
807,019
-250
-0% -$1.33K 0.05% 392
2019
Q1 		$4.69M Sell
807,269
-157,323
-16% -$1.62M 0.04% 396
2018
Q4 		$13M Buy
964,592
+56,434
+6% +$952K 0.14% 150
2018
Q3 		$17.6M Sell
908,158
-1,395
-0.2% -$29.7K 0.17% 131
2018
Q2 		$23.2M Sell
909,553
-94,534
-9% -$2.2M 0.25% 83
2018
Q1 		$20.2M Sell
1,004,087
-96,976
-9% -$2.26M 0.23% 97
2017
Q4 		$22.1M Sell
1,101,063
-634
-0.1% -$12.5K 0.26% 78
2017
Q3 		$22.8M Sell
1,101,697
-215,568
-16% -$3.65M 0.31% 59
2017
Q2 		$19.5M Sell
1,317,265
-19,805
-1% -$330K 0.29% 68
2017
Q1 		$21.3M Sell
1,337,070
-39,886
-3% -$575K 0.36% 50
2016
Q4 		$17.4M Sell
1,376,956
-320,170
-19% -$5.96M 0.33% 60
2016
Q3 		$47.5M Sell
1,697,126
-2,980
-0.2% -$100K 0.88% 14
2016
Q2 		$59.5M Sell
1,700,106
-550
-0% -$17.3K 1.26% 8
2016
Q1 		$46.6M Buy
1,700,656
+1,175,784
+224% +$34.6M 1.05% 12
2015
Q4 		$18M Buy
524,872
+475,961
+973% +$14.8M 0.43% 45
2015
Q3 		$1.41M Buy
+48,911
New +$2.09M 0.04% 389

Other funds holding DPLO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Cambridge Investment Research Advisors's DPLO Position: Q1 2020 in Review

Cambridge Investment Research Advisors sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 466,082 shares — an estimated $1.86M sold.

Cambridge Investment Research Advisors first reported a position in DPLO in Q3 2015 and held it in 18 quarters. The position peaked at $59.5M in Q2 2016. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.

  • Cambridge Investment Research Advisors reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 466,082 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $1.86M.
  • Cambridge Investment Research Advisors first reported a position in DIPLOMAT PHARMACY, INC. in Q3 2015 and held it in 18 quarters.
  • Cambridge Investment Research Advisors's DIPLOMAT PHARMACY, INC. position peaked at $59.5M in Q2 2016.
  • 1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2020, filed 8 May 2020.